Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1369L |
[Sar9,Met(O2)11]-Substance P acetate
[Sar9,Met(O2)11]-Substance P acetate(110880-55-2 free base) |
Neurokinin receptor | GPCR/G Protein; Neuroscience |
[Sar9,Met(O2)11]-Substance P acetate(110880-55-2 free base) 是一种速激肽 NK1 受体选择性激动剂。它是一种选择性速激肽 NK1 受体激动剂。它和 septide(每只大鼠 10-100 pmol,i.c.v.)在增加平均动脉血压 (MAP) 和心率 (HR),但它们的时间进程不同。两种激动剂都以剂量依赖性方式增加洗脸和吸鼻,而它是一种产生美容效果的化合物。 | |||
T7828 |
[Sar9,Met(O2)11]-Substance P
Bhsar-sp,NA,精氨酰-脯氨酰-赖氨酰-脯氨酰-谷氨酰-谷氨酰-苯丙氨酰-苯丙氨酰-SAR-亮氨酸-蛋氨酸[O2]-胺 |
Neurokinin receptor | GPCR/G Protein; Neuroscience |
[Sar9,Met(O2)11]-Substance P (NA) 是选择性速激肽NK1受体激动剂。 | |||
TP1369 |
[Sar9,Met(O2)11]-Substance P TFA(110880-55-2,free)
[Sar9,Met(O2)11]-Substance P TFA |
||
[Sar9,Met(O2)11]-Substance P TFA is a selective tachykinin NK1 receptor agonist.[Sar9,Met(O2)11]-Substance P and septide (10-100 pmol per rat, i.c.v.) are equipotent in increasing mean arterial blood pressure (MAP) and heart rate (HR), yet they have dissi | |||
T75769 | [Sar9,Met(O2)11]-Substance P TFA | ||
[Sar9,Met(O2)11]-Substance P TFA 是一种选择性的速激肽NK1受体激动剂。 | |||
TP1862L |
[Sar9] Substance P acetate(77128-75-7 free base)
|
Neurokinin receptor | GPCR/G Protein; Neuroscience |
[Sar9] Substance P acetate(77128-75-7 free base) 是一种 NK-1 受体激动剂。 rNK1 特异性激动剂 [Sar-9,Met(O2)11]-SP 模拟了 SP 对孕酮代谢的作用。 | |||
T70456 |
Nolpitantium Free Base
|
||
Nolpitantium Free Base is a highly selective nonpeptide antagonist of neurokinin-1 (NK1) receptor. Nolpitantium potently, selectively and competitively inhibited substance P binding to NK1 receptors from various animal species, including humans. In vitro, it was a potent antagonist in functional assays for NK1 receptors such as [Sar9, Met(O2)11]substance P-induced endothelium-dependent relaxation of rabbit pulmonary artery and contraction of guinea-pig ileum. Up to 1 mkM, Nolpitantium had no eff... | |||
TP1862 |
[Sar9] Substance P
|
||
[Sar9]-Substance P is one of NK-1 receptor agonist. The action of SP on progesterone metabolism was mimicked by the rNK1-specific agonist [Sar-9,Met(O2)11]-SP. |